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Recently, ﬂuconazole (FLZ) has been shown to improve survival and reduce multiorgan failure in experimental and clinical septic
shock. The mechanism by which FLZ aﬀords protection against sepsis remains obscure. This study examines the eﬀect of FLZ on
phagocytic activity of polymorphonuclear leukocytes (PMNs) in a rat model of septic shock by inducing fecal peritonitis in male
Wistar rats using intraperitoneal instillation (1mL/kg) of fecal suspension in saline (1 : 1w/v). Sham control rats received sterile
fecal suspension and vehicle treatment. FLZ was administered in the doses of 0, 3, 10, and 30mg/kg by gavage 30minutes before
fecal instillation. The samples of peritoneal ﬂuid were collected 8hours following fecal inoculation for the evaluation of phagocytic
response of PMNs using zymosan-induced luminol-dependent chemiluminescence (CL). Fecal peritonitis caused massive inﬁltra-
tion of PMNs in the peritoneal cavity (ANOVA F4,45 = 6.322, P<. 001). Although FLZ reduced the inﬁltration of PMNs, this eﬀect
was neither signiﬁcant nor dose dependent. The actual CL response was signiﬁcantly higher in the peritoneal ﬂuid of rats subjected
to peritonitis, which was signiﬁcantly and dose-dependently attenuated by FLZ treatment (ANOVA F4,45 = 11.048, P<. 001). Nor-
malization of CL response for 1000PMNs revealed that FLZ dose-dependently albeit insigniﬁcantly reduced the activity of PMNs.
The high dose of FLZ caused 2.29-fold decrement in the area under curve (AUC) pertaining to cumulative CL response. The ﬁnd-
ings of this study suggest that FLZ protects rats against septic shock by inhibiting PMN-mediated inﬂammatory cascade without
compromising their phagocytic activity.
INTRODUCTION
Sepsis and its sequelae are often lethal and consid-
ered to be the leading causes of mortality in intensive
care units [1, 2]. The cascade of events initiating from in-
fection to septic shock and multiorgan failure is poorly
understood. Polymorphonuclear leukocytes (PMNs) are
the ﬁrst line of defense against foreign antigens. Eﬀec-
tive host defense against bacterial infection depends on
the recruitment and activation of PMNs that localize, kill,
and clear the pathogens [3, 4]. On the other hand, mas-
sive inﬂammatory reaction resulting from uncontrolled
sequestration and prolonged activation of PMNs could
be potentially deleterious and has largely been implicated
in sepsis-mediated multiorgan dysfunction [5, 6, 7, 8].
Thus, PMNs (neutrophils and macrophages) could be re-
gardedasdual-edgedweapons,theircontrolledmigration
and optimal activity being essential for beneﬁcial eﬀects
[4, 9, 10]. Therapeutic strategies to attenuate excessive
acute inﬂammatory responses without compromising es-
sential host defense mechanisms would logically beneﬁt
in preventing neutrophil-mediated organ damage in sep-
tic shock [11, 12].
The immunomodulating feature of azole antifungal
drugs is a known fact [13, 14]. Fluconazole (FLZ) is a
well-tolerated antifungal drug with a demonstrated abil-
ity to reversibly penetrate into human PMNs [15]. Re-
cently, FLZ has been shown to improve survival and re-
duce multiorgan damage in experimental [16] and clin-
ical septic shock [17]. Since FLZ has no inherent an-
tibacterial properties, its beneﬁcial eﬀects in bacteremia
have been attributed to its action on the modulation of
neutrophils sequestration and activation [17]. However,
the ﬁndings of earlier studies regarding the eﬀect of FLZ
on the phagocytic response of PMNs are controversial.
Only few studies have reported enhanced bactericidal ac-
tivity of PMNs in presence of FLZ [18, 19]. Even FLZ-
induced increase in the phagocytosis and intracellular
killing of candida have been linked to its direct eﬀect on
yeast rather than on phagocytes [19]. On the other hand,
many investigators observed that FLZ did not aﬀect the
phagocytic activity of PMNs [13, 20, 21, 22, 23, 24, 25].
It is therefore intriguing to better understand the na-
ture of interaction between FLZ and PMNs in sepsis,
and the present investigation is an attempt in this direc-
tion.10 Haseeb Ahmad Khan 2005:1 (2005)
Table 1. Eﬀect of ﬂuconazole (FLZ) on luminol-dependent chemiluminescence response of phagocyting leukocytes in the peritoneal
ﬂuid of rats with septic shock.
Treatment group
Leukocytes count in
peritoneal ﬂuid per
mm3
RLU (integral value) RLU (peak value)
Per 500nL
peritoneal ﬂuid
Per 1000
leukocytes
Per 500nL
peritoneal ﬂuid
Per 1000
leukocytes
Control (sham) 9440 ±780.2 6.67 ±3.64 1.16 ±.57 8.40 ±3.10 1.61 ±0.47
FP 27590 ±3007.2# 276.94 ±39.99# 21.21 ±2.97# 188.30 ±25.19# 14.42 ±1.81#
FP + FLZ 3 23730 ±3397.6 208.60 ±30.85 18.23 ±2.33 140.40 ±19.33 12.28 ±1.42
FP + FLZ 10 19580 ±2948.7 164.86 ±28.24∗ 17.85 ±2.39 110.80 ±19.28∗ 12.00 ±1.61
FP + FLZ 30 21630 ±2589.3 144.78 ±33.78∗∗ 13.06 ±2.94 97.70 ±23.25∗∗ 8.87 ±2.05
#d e n o t e sP<. 001 versus control group, ∗P<. 05, and ∗∗P<. 01 versus FP group using Dunnett’s multiple comparison test. RLU (relative light unit)
is an arbitrary unit of chemiluminescence measurement.
MATERIALS AND METHODS
Animals
A d u l tm a l eW i s t a rr a t sw e r eh o u s e di nat e m p e r a t u r e -
controlled room maintained on 12-hour light/dark
cycles.Thestandardlaboratoryfoodandwaterwerefreely
available ad libitum except an overnight fasting before in-
duction of experimental sepsis.
Druganddosing
Animals were divided into 5 groups of 10 animals
each. FLZ was administered orally in the doses of 0, 3, 10,
and 30mg/kg body weight, 30minutes before fecal inocu-
lation. This dose regimen was selected on the basis of our
earlier study [16]. Control rats received sham surgery and
vehicle treatment.
Inductionofsepsisinrats
A fecal peritonitis (FP) model was used to induce
a c u t es e p s i si nr a t s[ 26]. Homogeneous fecal suspension
was prepared by dissolving freshfeces(1 : 1w/v in normal
saline) obtained surgically from the caecum of nonfasted
healthyrats,andusedwithin2hours.Asmallincisionwas
made in the abdomen of ether-anesthetized rats for in-
traperitoneal instillation of fecal suspension at a dosage of
1mL/kgbodyweightofanimals.Controlanimalsreceived
preautoclaved fecal suspension. The wound was closed
asepticallyandanimalsreturnedtohomecages.Thespec-
imens of peritoneal ﬂuid were collected 8hours following
fecal inoculation. The samples were diluted (100 folds)
in Hank’s balanced salt solution (HBSS) containing 0.1%
gelatin and promptly analyzed.
Measurementofphagocytosis
A sensitive procedure based on zymosan-induced
luminol-enhanced chemiluminescence (CL) was used to
m e a s u r ep h a g o c yt i cr e s p o n s eo fl e u k o c yt e s[ 27]. Fifty mi-
crolitersofpredilutedperitonealﬂuidsamplesweremixed
with 150µL of reaction mixture (4 × 10−4 M luminol +
50µg opsonized zymosan + 0.1 %g e l a t i ni nH B S S )i n
the well of an opaque cliniplate (Labsystems, Finland).
The CL signal produced by phagocytosing leukocytes was
measured at 37◦C in a luminometer (Model Luminoskan
RT, Labsystems). Thirty cycles of measurements using
5-second counting time and 70-second interval time
were performed for each sample. The CL intensity was
expressed as relative light unit (RLU). Leukocytes were
counted in all the samples using a haemocytometer.
The CL response (actual or normalized) has been
reported as peak value (highest signal among 30 mea-
surements) and integral value (integration of all the sig-
nals for 30-minute measurement time). The actual CL
response corresponds to 50µL of 100-fold diluted peri-
toneal ﬂuid sample (equivalent to 500nL of peritoneal
ﬂuid), irrespective of the number of leukocytes within
the sample. The normalized CL (per 1000 leukocytes)
was used to compare phagocytic activity of the leuko-
cytes in diﬀerent treatment groups. The area under curve
(AUC) was measured (in triplicate) using the public do-
main image processing and analysis program developed
at the National Institute of Health, USA. The PC version
of this program, known as Scion Image, is available on
http://www.scioncorp.com for free download from Scion,
Md, USA.
Statisticalanalysis
Data were analyzed by one-way analysis of variance
(ANOVA) followed by Dunnett’s multiple comparison
test. Pearson’s test was used for parametric correlations.
The statistical signiﬁcance was deﬁned by P<. 05.
RESULTS
Leukocytecount
The leukocyte count was signiﬁcantly increased in
the peritoneal ﬂuid of rats subjected to FP (27590 ±
3007mm3) as compared to sham control rats (9440 ±
780mm3)( A N O V AF 4,45 = 6.322, P<. 001). Pretreat-
ment with FLZ attenuated leukocyte count in the peri-
toneal ﬂuid, however this eﬀect was neither dose depen-
dent nor signiﬁcant (Table 1).2005:1 (2005) Fluconazole Modulates Inﬂammatory Cascade 11
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Figure 1. Real-time chemiluminescence (CL) signals from individual samples showing the eﬀect of ﬂuconazole (FLZ) on phagocytic
activity of leukocytes in the peritoneal ﬂuid (500nL) of rats with fecal peritonitis (upper-panel line graphs). Areas under curves were
used to display cumulative representation of all the samples and to measure area under curve (AUC) (lower panel). x-axes show the
measurement time of each sample in the luminometer.
ActualCLresponse(effectivephagocytosis)
Both integral and peak CL responses (RLUs) were sig-
niﬁcantlyhigherinperitonitisgroupascomparedtosham
control (Table 1). Administration of FLZ signiﬁcantly
and dose-dependently attenuated the integral (ANOVA
F4,45 = 11.048, P<. 001) and peak (ANOVA F4,45 =
11.345, P<. 001) CL responses (Table 1). The represen-
tative real-time CL signals for control and FP with or
without FLZ (30mg/kg) groups are shown in Figure 1.
The AUC of peritonitis group (1031.38±16.31mm2)w a s
17.56-fold greater than sham control (58.72±3.12mm2).
TreatmentsofratswithFLZ(30mg/kg)markedlyreduced
(2.29-fold) the AUC as compared to peritonitis alone
group (Figure 1, lower panel).
NormalizedCLresponse(leukocyteactivity)
The normalization of CL to 1000 leukocytes showed
signiﬁcantly high phagocytic response in peritonitis
g r o u pa sc o m p a r e dt os h a mc o n t r o l( Table 1). Both inte-
gral(ANOVAF4,45 = 10.754,P<. 001)andpeak(ANOVA
F4,45 = 10.164, P<. 001) normalized RLUs were signiﬁ-
cantly higher in the peritonitis alone group. Pretreatment
with FLZ dose-dependently reduced the normalized CL
responses; however, these eﬀects failed to reach the signif-
icance level (Table 1).
CorrelationbetweenintegralandpeakRLUs
A highly signiﬁcant correlation (correlation coeﬃ-
cient, R = 0.995, P<. 001) was observed between inte-
gral and peak CL responses, irrespective of the treatments
administered (Figure 2).
Correlationbetweenleukocytecount
andintegralRLUs
T h ep l o to fl e u k o c y t ec o u n tv e r s u si n t e g r a lR L U si s
shown in Figure 3. The correlation was statistically signif-
icant(R = 0.693,P<. 001);however,thedatapointsfrom
various treatment groups appeared staggered around the
trend line (Figure 3).12 Haseeb Ahmad Khan 2005:1 (2005)
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Figure 2. Correlation between the two parameters used to mea-
sure chemiluminescence (CL) response of phagocyting leuko-
cytes. Peak value represents the maximal signal intensity among
the 30 measurement points, whereas the integral value is the to-
tal integration of CL signals for a 30-minute period.
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Figure 3. Correlation between chemiluminescence signal and
leukocyte count in the peritoneal ﬂuid samples.
DISCUSSION
Fecal peritonitis caused massive inﬁltration of PMNs
in peritoneum (Table 1), which is in accordance with
our earlier study [28]. Administration of FLZ insignif-
icantly reduced the sequestration of PMNs to the
infectious focus.PMNs migration into the peritoneal cav-
ity in response to FP is an important mechanism of
host defense against bacterial invasion as the exudative
PMNs localize and contain infection by phagocytizing
and killing bacteria [29, 30, 31]. The migrated PMNs in
the peritonitis group showed a highly signiﬁcant upreg-
ulation of their phagocytic activity as compared to sham
control (Table 1, Figure 1). Although resting PMNs (neu-
trophils) consume little O2, their activation involves a
marked increase in O2 uptake, often known as “respira-
tory burst” that results in the production of potentially
toxic reactive oxygen species (ROS) [32, 33]. The upsurge
in O2 uptake is associated with the activation of an enzy-
matic process that oxidizes NADPH to NADP+, the elec-
trontransferbeingusedtoreduceO2 intosuperoxiderad-
ical (O
·−
2 ) that further reacts with H2O2 to produce hy-
droxyl radical (OH·)[ 34]. An enzyme, myeloperoxidase
(MPO) is released from activated neutrophils that form
hypochlorite (HOCl) after reaction with H2O2 and Cl−.
Activated neutrophils and macrophages are also able to
release nitric oxide that combines with O
·−
2 to produce
peroxynitrile (ONOO−)[ 35]. All these ROS have a ten-
dency to produce CL in presence of luminol [36, 37, 38].
Therefore, a high CL signal from migrated PMNs during
sepsis indicates excessive generation of ROS that might
trigger pathways for host damage [39, 40, 41]. The dele-
terious eﬀects of ROS are limited by antioxidant de-
fensesystems.IncreasedproductionofROSanddecreased
antioxidant status have been reported in septic shock pa-
tients [42, 43, 44, 45].
It is widely accepted that the multiple organ dysfunc-
tion is a consequence of generalized inﬂammatory re-
action whereas infection per se triggers these pathways
[6, 46]. The natural resolution of acute inﬂammation in-
volves bulk clearance of extravasated inﬂammatory cells
in an ordered manner [47]. However, an imbalance be-
tween the clearance and inﬁltration of PMNs and/or dis-
ruption of equilibrium between bacterial load and ex-
tent of phagocytosing PMNs could be deleterious to host
cells. Recent studies have shown that agents with anti-
inﬂammatory and/or antioxidant properties signiﬁcantly
protect against experimental [48, 49, 50, 51, 52] and clin-
ical septic shock [53, 54].
Administration of FLZ signiﬁcantly and dose-
dependently reduced the CL response of PMNs in the
rats with septic shock (Table 1). On the other hand,
the normalized CL values (per 1000 leukocytes) showed
that the activity of PMNs is only insigniﬁcantly af-
fected by FLZ, which is supported by earlier ﬁndings
[13, 20, 21, 22, 23, 24, 25]. Taken together, these obser-
vations suggest that FLZ eﬀectively counteracts excessive
ROS generation by PMNs without signiﬁcantly altering
their functionality. The eﬀect of FLZ on controlling the
ROS formation by activated PMNs is further evidenced
by more than 50% reduction of AUC in FLZ (30mg/kg)
group as compared to vehicle-treated rats (Figure 1). The
correlation between integral and peak CL responses was
independent of treatment groups, suggesting a direct
relation between the activity of PMN and sustained
production of ROS (Figure 2). Although the correlation
analysis between PMNs count and CL response showed2005:1 (2005) Fluconazole Modulates Inﬂammatory Cascade 13
a positive trend, data points from various treatment
groups appeared staggered (Figure 3). This within-group
variation may be attributed to diﬀerent magnitudes
of immunity in animals. However, this ﬁnding points
towards the usefulness of individual assessment of septic
shock patients with regard to PMNs counts and activity
for selecting the eﬀective dose regimen of FLZ.
In conclusion, the protective eﬀects of FLZ in experi-
mental sepsis may be attributed to the inhibition of ROS-
mediated proinﬂammatory cascade without compromis-
ing eﬀective pathogen clearance. However, the relevance
of these ﬁndings with human septic shock remains un-
clear and warrants further clinical study.
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